Urano M, et al. - Researchers assessed the clinicopathological implications of forkhead-box protein A1 (FOXA1) in salivary duct carcinoma (SDC) as well as biomarker status and clinical outcome. For this investigation, 142 SDCs were involved. Results revealed that SDCs with a higher FOXA1 labelling index was correlated with longer overall survival and progression-free survival. The study findings suggested that FOXA1 might biologically interact with the androgen receptor and PI3K signaling pathways in SDC and could be a biomarker correlated with a favorable prognosis.